World Health Organization

Asthma.

() ()Blanco I. Diego I. Bueno P. et al.

Geographic distribution of COPD prevalence in the world displayed by geographic information system maps.

Eur Respir J. 54https://doi.org/10.1183/13993003.00610-2019World Health Organization

Chronic obstructive pulmonary disease (COPD).

() ()Sharma S. Khurana S. Federman A.D. et al.

Asthma-chronic obstructive pulmonary disease overlap.

Immunol Allergy Clin North Am. 40: 565-573Morgan B.W. Grigsby M.R. Siddharthan T. et al.

Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries.

J Allergy Clin Immunol. 143: 1598-1606Global Strategy for Asthma Management and Prevention

Global strategy for asthma management and preventsion (2021 update).

() ()Celli B.R. MacNee W. Force A.E.T.

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Eur Respir J. 23: 932-946Broaddus V.C. Mason R.J. Ernst J.D. Murray et al.Nadel’s textbook of respiratory medicine. 6th edition. Elsevier Saunders, Desai M. Oppenheimer J. Tashkin D.P.

Asthma-chronic obstructive pulmonary disease overlap syndrome: What we know and what we need to find out.

Ann Allergy Asthma Immunol. 118: 241-245Hosseini M. Almasi-Hashiani A. Sepidarkish M. et al.

Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis.

Respir Res. 20: 229Spellberg B. Edwards Jr., J.E.

Type 1/Type 2 immunity in infectious diseases.

Clin Infect Dis. 32: 76-102

Type 2 inflammation in asthma--present in most, absent in many.

Nat Rev Immunol. 15: 57-65Saetta M. Di Stefano A. Maestrelli P. et al.

Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis.

Am Rev Respir Dis. 147: 301-306O'Shaughnessy T.C. Ansari T.W. Barnes N.C. et al.

Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

Am J Respir Crit Care Med. 155: 852-857Di Stefano A. Caramori G. Ricciardolo F.L. et al.

Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.

Clin Exp Allergy. 34: 1156-1167Di Stefano A. Capelli A. Lusuardi M. et al.

Severity of airflow limitation is associated with severity of airway inflammation in smokers.

Am J Respir Crit Care Med. 158: 1277-1285Hogg J.C. Chu F. Utokaparch S. et al.

The nature of small-airway obstruction in chronic obstructive pulmonary disease.

N Engl J Med. 350: 2645-2653

Cytokines in chronic obstructive pulmonary disease.

Eur Respir J Suppl. 34: 50s-59s

Oxidative stress in COPD.

Chest. 144: 266-273

Global Initiative for Asthma, and Global Initiative for Chronic Obstructive Lung Disease. Diagnosis and Initial treatment of asthma, COPD and asthma-COPD overlap. Available at: ginasthma.org, 2017. Accessed December 2, 2021.

Boulet L.P. Lemiere C. Archambault F. et al.

Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation.

Chest. 129: 661-668Morissette M. Godbout K. Cote A. et al.

Asthma COPD overlap: insights into cellular and molecular mechanisms.

Mol Aspects Med. 11: 101021Botelho F.M. Llop-Guevara A. Trimble N.J. et al.

Cigarette smoke differentially affects eosinophilia and remodeling in a model of house dust mite asthma.

Am J Respir Cell Mol Biol. 45: 753-760Broekema M. ten Hacken N.H. Volbeda F. et al.

Airway epithelial changes in smokers but not in ex-smokers with asthma.

Am J Respir Crit Care Med. 180: 1170-1178Ravensberg A.J. Slats A.M. van Wetering S. et al.

CD8(+) T cells characterize early smoking-related airway pathology in patients with asthma.

Respir Med. 107: 959-966Saetta M. Baraldo S. Corbino L. et al.

CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 160: 711-717Almetwally A.A. Bin-Jumah M. Allam A.A.

Ambient air pollution and its influence on human health and welfare: an overview.

Environ Sci Pollut Res Int. 27: 24815-24830Hehua Z. Qing C. Shanyan G. et al.

The impact of prenatal exposure to air pollution on childhood wheezing and asthma: a systematic review.

Environ Res. 159: 519-530Arbex M.A. de Souza Conceicao G.M. Cendon S.P. et al.

Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits.

J Epidemiol Community Health. 63: 777-783Mocelin H.T. Fischer G.B. Bush A.

Adverse early-life environmental exposures and their repercussions on adult respiratory health.

J Pediatr (Rio J). 98: S86-S95

Pathogenesis of asthma.

Clin Exp Allergy. 38: 872-897Wong G.W. Brunekreef B. Ellwood P. et al.

Cooking fuels and prevalence of asthma: a global analysis of phase three of the international study of asthma and allergies in childhood (ISAAC).

Lancet Respir Med. 1: 386-394Wang M. Aaron C.P. Madrigano J. et al.

Association between long-term exposure to ambient air pollution and change in quantitatively assessed emphysema and lung function.

JAMA. 322: 546-556Seth D. Saini S. Poowuttikul P.

Pediatric inner-city asthma.

Immunol Allergy Clin North Am. 41: 599-611Chana K.K. Fenwick P.S. Nicholson A.G. et al.

Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.

J Allergy Clin Immunol. 133: 207-216.e1-11

Role of alveolar macrophages in chronic obstructive pulmonary disease.

Front Immunol. 5: 435

Cellular and molecular mechanisms of asthma and COPD.

Clin Sci (Lond). 131: 1541-1558Culpitt S.V. Rogers D.F. Shah P. et al.

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 167: 24-31Halwani R. Al-Muhsen S. Hamid Q.

T helper 17 cells in airway diseases: from laboratory bench to bedside.

Chest. 143: 494-501Rosenberg H.F. Dyer K.D. Foster P.S.

Eosinophils: changing perspectives in health and disease.

Nat Rev Immunol. 13: 9-22Dunican E.M. Elicker B.M. Gierada D.S. et al.

Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.

J Clin Invest. 128: 997-1009Pavord I.D. Chanez P. Criner G.J. et al.

Mepolizumab for eosinophilic chronic obstructive pulmonary disease.

N Engl J Med. 377: 1613-1629Trejo Bittar H.E. Yousem S.A. Wenzel S.E.

Pathobiology of severe asthma.

Annu Rev Pathol. 10: 511-545

Airway mucus function and dysfunction.

N Engl J Med. 363: 2233-2247

The cytokine network in asthma and chronic obstructive pulmonary disease.

J Clin Invest. 118: 3546-3556

Inflammatory mediators in chronic obstructive pulmonary disease.

Curr Drug Targets Inflamm Allergy. 4: 619-625Ying S. O'Connor B. Ratoff J. et al.

Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease.

J Immunol. 181: 2790-2798Mitchell P.D. O'Byrne P.M.

Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma.

Pharmacol Ther. 169: 104-112Demenais F. Margaritte-Jeannin P. Barnes K.C. et al.

Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks.

Nat Genet. 50: 42-53Moffatt M.F. Gut I.G. Demenais F. et al.

A large-scale, consortium-based genomewide association study of asthma.

N Engl J Med. 363: 1211-1221Sakornsakolpat P. Prokopenko D. Lamontagne M. et al.

Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.

Nat Genet. 51: 494-505Zhao X. Qiao D. Yang C. et al.

Whole genome sequence analysis of pulmonary function and COPD in 19,996 multi-ethnic participants.

Nat Commun. 11: 5182John C. Guyatt A.L. Shrine N. et al.

Genetic associations and architecture of asthma-COPD overlap.

Chest. https://doi.org/10.1016/j.chest.2021.12.674Bisgaard H. Hermansen M.N. Buchvald F. et al.

Childhood asthma after bacterial colonization of the airway in neonates.

N Engl J Med. 357: 1487-1495Teo S.M. Tang H.H.F. Mok D. et al.

Airway microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease.

Cell Host Microbe. 24: 341-352.e5Ghebre M.A. Pang P.H. Diver S. et al.

Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.

J Allergy Clin Immunol. 141: 2027-2036.e12Benayoun L. Druilhe A. Dombret M.C. et al.

Airway structural alterations selectively associated with severe asthma.

Am J Respir Crit Care Med. 167: 1360-1368Pepe C. Foley S. Shannon J. et al.

Differences in airway remodeling between subjects with severe and moderate asthma.

J Allergy Clin Immunol. 116: 544-549